Literature DB >> 8880690

Neurotransmitter amino acids in cerebrospinal fluid of patients with Parkinson's disease.

F J Jiménez-Jiménez1, J A Molina, C Vargas, P Gómez, J A Navarro, J Benito-León, M Ortí-Pareja, T Gasalla, E Cisneros, J Arenas.   

Abstract

We measured the CSF and plasma levels of glutamate, glutamine, aspartate (only in plasma), asparagine, glutamine, glycine and GABA in 31 patients with Parkinson's disease and in 45 matched controls. We used an ion-exchange chromatography method. When compared to controls, PD patients had similar CSF levels of glutamate, glutamine, asparagine, and glycine higher CSF GABA levels higher plasma levels of glutamine, asparagine, and glycine, and lower plasma levels of aspartate. The CSF levels of the amino acids measured were not correlated with the clinical features of PD. Our results that CSF GABA levels are not decreased in PD as previously suggested.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8880690     DOI: 10.1016/0022-510x(96)00115-3

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  13 in total

1.  Amino acids and biogenic amines in cerebrospinal fluid of patients with Parkinson's disease.

Authors:  S Engelborghs; B Marescau; P P De Deyn
Journal:  Neurochem Res       Date:  2003-08       Impact factor: 3.996

2.  NMR Metabolomics Analysis of Parkinson's Disease.

Authors:  Shulei Lei; Robert Powers
Journal:  Curr Metabolomics       Date:  2013

3.  Metabolomics of blood reveals age-dependent pathways in Parkinson's Disease.

Authors:  Nicola D'Ascenzo; Emanuele Antonecchia; Antonella Angiolillo; Victor Bender; Marco Camerlenghi; Qingguo Xie; Alfonso Di Costanzo
Journal:  Cell Biosci       Date:  2022-07-06       Impact factor: 9.584

Review 4.  Mitochondrial Dysfunction and Synaptic Transmission Failure in Alzheimer's Disease.

Authors:  Lan Guo; Jing Tian; Heng Du
Journal:  J Alzheimers Dis       Date:  2017       Impact factor: 4.472

Review 5.  Therapeutic potential of targeting glutamate receptors in Parkinson's disease.

Authors:  Clare Finlay; Susan Duty
Journal:  J Neural Transm (Vienna)       Date:  2014-02-21       Impact factor: 3.575

6.  Metabolic profiling of Parkinson's disease: evidence of biomarker from gene expression analysis and rapid neural network detection.

Authors:  Shiek Ssj Ahmed; Winkins Santosh; Suresh Kumar; Hema T Thanka Christlet
Journal:  J Biomed Sci       Date:  2009-07-13       Impact factor: 8.410

7.  Correlations between plasma levels of amino acids and nonmotor symptoms in Parkinson's disease.

Authors:  Qing Tong; Qinrong Xu; Qiang Xia; Yongsheng Yuan; Li Zhang; Hongbin Sun; Han Shan; Kezhong Zhang
Journal:  J Neural Transm (Vienna)       Date:  2014-07-25       Impact factor: 3.575

Review 8.  Targeting glutamate receptors to tackle the pathogenesis, clinical symptoms and levodopa-induced dyskinesia associated with Parkinson's disease.

Authors:  Susan Duty
Journal:  CNS Drugs       Date:  2012-12       Impact factor: 5.749

9.  Changes in amino acids and nitric oxide concentration in cerebrospinal fluid during labor pain.

Authors:  Rama Sethuraman; Tat-Leang Lee; Jen-Wun Chui; Shinro Tachibana
Journal:  Neurochem Res       Date:  2006-08-29       Impact factor: 4.414

10.  Alterations in energy/redox metabolism induced by mitochondrial and environmental toxins: a specific role for glucose-6-phosphate-dehydrogenase and the pentose phosphate pathway in paraquat toxicity.

Authors:  Shulei Lei; Laura Zavala-Flores; Aracely Garcia-Garcia; Renu Nandakumar; Yuting Huang; Nandakumar Madayiputhiya; Robert C Stanton; Eric D Dodds; Robert Powers; Rodrigo Franco
Journal:  ACS Chem Biol       Date:  2014-07-07       Impact factor: 5.100

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.